Part 1
Part 2
Part 3
Part 5
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them. TCR-Based Antibody report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TCR-Based Antibody market is projected to reach US$ 1787.4 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2029. Demand from Hospitals and Specialized Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TCR-Based Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, TCR-Based Antibody key manufacturers include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. Adaptimmune Therapeutics, Celgene, Immunocore are top 3 players and held % sales share in total in 2022. TCR-Based Antibody can be divided into NY-ESO-1, p53, WT-1 and EBv, etc. NY-ESO-1 is the mainstream product in the market, accounting for % sales share globally in 2022. TCR-Based Antibody is widely used in various fields, such as Hospitals, Specialized Clinics, Pharma and Biotech Research Laboratories. and Gene Therapy Centers, etc. Hospitals provides greatest supports to the TCR-Based Antibody industry development. In 2022, global % sales of TCR-Based Antibody went into Hospitals filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global TCR-Based Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Adaptimmune Therapeutics Celgene Immunocore Kuur Therapeutics Lion TCR Kite Pharma Takara Bio Ziopharm Oncology GlaxoSmithKline Merck Juno Theraprutics Segment by Type NY-ESO-1 p53 WT-1 EBv Others Segment by Application Hospitals Specialized Clinics Pharma and Biotech Research Laboratories. Gene Therapy Centers Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the TCR-Based Antibody market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TCR-Based Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TCR-Based Antibody industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of TCR-Based Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TCR-Based Antibody introduction, etc. TCR-Based Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of TCR-Based Antibody market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
1 TCR-Based Antibody Market Overview
1.1 TCR-Based Antibody Product Overview
1.2 TCR-Based Antibody Market Segment by Type
1.2.1 NY-ESO-1
1.2.2 p53
1.2.3 WT-1
1.2.4 EBv
1.2.5 Others
1.3 Global TCR-Based Antibody Market Size by Type
1.3.1 Global TCR-Based Antibody Market Size Overview by Type (2018-2029)
1.3.2 Global TCR-Based Antibody Historic Market Size Review by Type (2018-2023)
1.3.3 Global TCR-Based Antibody Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America TCR-Based Antibody Sales Breakdown by Type (2018-2023)
1.4.2 Europe TCR-Based Antibody Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific TCR-Based Antibody Sales Breakdown by Type (2018-2023)
1.4.4 Latin America TCR-Based Antibody Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa TCR-Based Antibody Sales Breakdown by Type (2018-2023)
2 Global TCR-Based Antibody Market Competition by Company
2.1 Global Top Players by TCR-Based Antibody Sales (2018-2023)
2.2 Global Top Players by TCR-Based Antibody Revenue (2018-2023)
2.3 Global Top Players by TCR-Based Antibody Price (2018-2023)
2.4 Global Top Manufacturers TCR-Based Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 TCR-Based Antibody Market Competitive Situation and Trends
2.5.1 TCR-Based Antibody Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by TCR-Based Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TCR-Based Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into TCR-Based Antibody Market
2.8 Key Manufacturers TCR-Based Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 TCR-Based Antibody Status and Outlook by Region
3.1 Global TCR-Based Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global TCR-Based Antibody Historic Market Size by Region
3.2.1 Global TCR-Based Antibody Sales in Volume by Region (2018-2023)
3.2.2 Global TCR-Based Antibody Sales in Value by Region (2018-2023)
3.2.3 Global TCR-Based Antibody Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global TCR-Based Antibody Forecasted Market Size by Region
3.3.1 Global TCR-Based Antibody Sales in Volume by Region (2024-2029)
3.3.2 Global TCR-Based Antibody Sales in Value by Region (2024-2029)
3.3.3 Global TCR-Based Antibody Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global TCR-Based Antibody by Application
4.1 TCR-Based Antibody Market Segment by Application
4.1.1 Hospitals
4.1.2 Specialized Clinics
4.1.3 Pharma and Biotech Research Laboratories.
4.1.4 Gene Therapy Centers
4.1.5 Others
4.2 Global TCR-Based Antibody Market Size by Application
4.2.1 Global TCR-Based Antibody Market Size Overview by Application (2018-2029)
4.2.2 Global TCR-Based Antibody Historic Market Size Review by Application (2018-2023)
4.2.3 Global TCR-Based Antibody Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America TCR-Based Antibody Sales Breakdown by Application (2018-2023)
4.3.2 Europe TCR-Based Antibody Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific TCR-Based Antibody Sales Breakdown by Application (2018-2023)
4.3.4 Latin America TCR-Based Antibody Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa TCR-Based Antibody Sales Breakdown by Application (2018-2023)
5 North America TCR-Based Antibody by Country
5.1 North America TCR-Based Antibody Historic Market Size by Country
5.1.1 North America TCR-Based Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America TCR-Based Antibody Sales in Volume by Country (2018-2023)
5.1.3 North America TCR-Based Antibody Sales in Value by Country (2018-2023)
5.2 North America TCR-Based Antibody Forecasted Market Size by Country
5.2.1 North America TCR-Based Antibody Sales in Volume by Country (2024-2029)
5.2.2 North America TCR-Based Antibody Sales in Value by Country (2024-2029)
6 Europe TCR-Based Antibody by Country
6.1 Europe TCR-Based Antibody Historic Market Size by Country
6.1.1 Europe TCR-Based Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe TCR-Based Antibody Sales in Volume by Country (2018-2023)
6.1.3 Europe TCR-Based Antibody Sales in Value by Country (2018-2023)
6.2 Europe TCR-Based Antibody Forecasted Market Size by Country
6.2.1 Europe TCR-Based Antibody Sales in Volume by Country (2024-2029)
6.2.2 Europe TCR-Based Antibody Sales in Value by Country (2024-2029)
7 Asia-Pacific TCR-Based Antibody by Region
7.1 Asia-Pacific TCR-Based Antibody Historic Market Size by Region
7.1.1 Asia-Pacific TCR-Based Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific TCR-Based Antibody Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific TCR-Based Antibody Sales in Value by Region (2018-2023)
7.2 Asia-Pacific TCR-Based Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific TCR-Based Antibody Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific TCR-Based Antibody Sales in Value by Region (2024-2029)
8 Latin America TCR-Based Antibody by Country
8.1 Latin America TCR-Based Antibody Historic Market Size by Country
8.1.1 Latin America TCR-Based Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America TCR-Based Antibody Sales in Volume by Country (2018-2023)
8.1.3 Latin America TCR-Based Antibody Sales in Value by Country (2018-2023)
8.2 Latin America TCR-Based Antibody Forecasted Market Size by Country
8.2.1 Latin America TCR-Based Antibody Sales in Volume by Country (2024-2029)
8.2.2 Latin America TCR-Based Antibody Sales in Value by Country (2024-2029)
9 Middle East and Africa TCR-Based Antibody by Country
9.1 Middle East and Africa TCR-Based Antibody Historic Market Size by Country
9.1.1 Middle East and Africa TCR-Based Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa TCR-Based Antibody Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa TCR-Based Antibody Sales in Value by Country (2018-2023)
9.2 Middle East and Africa TCR-Based Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa TCR-Based Antibody Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa TCR-Based Antibody Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Adaptimmune Therapeutics
10.1.1 Adaptimmune Therapeutics Company Information
10.1.2 Adaptimmune Therapeutics Introduction and Business Overview
10.1.3 Adaptimmune Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Adaptimmune Therapeutics TCR-Based Antibody Products Offered
10.1.5 Adaptimmune Therapeutics Recent Development
10.2 Celgene
10.2.1 Celgene Company Information
10.2.2 Celgene Introduction and Business Overview
10.2.3 Celgene TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Celgene TCR-Based Antibody Products Offered
10.2.5 Celgene Recent Development
10.3 Immunocore
10.3.1 Immunocore Company Information
10.3.2 Immunocore Introduction and Business Overview
10.3.3 Immunocore TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Immunocore TCR-Based Antibody Products Offered
10.3.5 Immunocore Recent Development
10.4 Kuur Therapeutics
10.4.1 Kuur Therapeutics Company Information
10.4.2 Kuur Therapeutics Introduction and Business Overview
10.4.3 Kuur Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Kuur Therapeutics TCR-Based Antibody Products Offered
10.4.5 Kuur Therapeutics Recent Development
10.5 Lion TCR
10.5.1 Lion TCR Company Information
10.5.2 Lion TCR Introduction and Business Overview
10.5.3 Lion TCR TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lion TCR TCR-Based Antibody Products Offered
10.5.5 Lion TCR Recent Development
10.6 Kite Pharma
10.6.1 Kite Pharma Company Information
10.6.2 Kite Pharma Introduction and Business Overview
10.6.3 Kite Pharma TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kite Pharma TCR-Based Antibody Products Offered
10.6.5 Kite Pharma Recent Development
10.7 Takara Bio
10.7.1 Takara Bio Company Information
10.7.2 Takara Bio Introduction and Business Overview
10.7.3 Takara Bio TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takara Bio TCR-Based Antibody Products Offered
10.7.5 Takara Bio Recent Development
10.8 Ziopharm Oncology
10.8.1 Ziopharm Oncology Company Information
10.8.2 Ziopharm Oncology Introduction and Business Overview
10.8.3 Ziopharm Oncology TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Ziopharm Oncology TCR-Based Antibody Products Offered
10.8.5 Ziopharm Oncology Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GlaxoSmithKline TCR-Based Antibody Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Merck
10.10.1 Merck Company Information
10.10.2 Merck Introduction and Business Overview
10.10.3 Merck TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merck TCR-Based Antibody Products Offered
10.10.5 Merck Recent Development
10.11 Juno Theraprutics
10.11.1 Juno Theraprutics Company Information
10.11.2 Juno Theraprutics Introduction and Business Overview
10.11.3 Juno Theraprutics TCR-Based Antibody Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Juno Theraprutics TCR-Based Antibody Products Offered
10.11.5 Juno Theraprutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 TCR-Based Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 TCR-Based Antibody Industrial Chain Analysis
11.4 TCR-Based Antibody Market Dynamics
11.4.1 TCR-Based Antibody Industry Trends
11.4.2 TCR-Based Antibody Market Drivers
11.4.3 TCR-Based Antibody Market Challenges
11.4.4 TCR-Based Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 TCR-Based Antibody Distributors
12.3 TCR-Based Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables Table 1. Major Company of NY-ESO-1 Table 2. Major Company of p53 Table 3. Major Company of WT-1 Table 4. Major Company of EBv Table 5. Major Company of Others Table 6. Global TCR-Based Antibody Sales by Type 2018 VS 2022 VS 2029 (US$ Million) Table 7. Global TCR-Based Antibody Sales by Type (2018-2023) & (K Units) Table 8. Global TCR-Based Antibody Sales Market Share in Volume by Type (2018-2023) Table 9. Global TCR-Based Antibody Sales by Type (2018-2023) & (US& Million) Table 10. Global TCR-Based Antibody Market Share in Value by Type (2018-2023) Table 11. Global TCR-Based Antibody Price by Type (2018-2023) & (US$/Unit) Table 12. Global TCR-Based Antibody Sales by Type (2024-2029) & (K Units) Table 13. Global TCR-Based Antibody Sales Market Share in Volume by Type (2024-2029) Table 14. Global TCR-Based Antibody Sales by Type (2024-2029) & (US$ Million) Table 15. Global TCR-Based Antibody Sales Market Share in Value by Type (2024-2029) Table 16. Global TCR-Based Antibody Price by Type (2024-2029) & (US$/Unit) Table 17. North America TCR-Based Antibody Sales by Type (2018-2023) & (K Units) Table 18. North America TCR-Based Antibody Sales by Type (2018-2023) & (US$ Million) Table 19. Europe TCR-Based Antibody Sales (K Units) by Type (2018-2023) Table 20. Europe TCR-Based Antibody Sales by Type (2018-2023) & (US$ Million) Table 21. Asia-Pacific TCR-Based Antibody Sales (K Units) by Type (2018-2023) Table 22. Asia-Pacific TCR-Based Antibody Sales by Type (2018-2023) & (US$ Million) Table 23. Latin America TCR-Based Antibody Sales (K Units) by Type (2018-2023) Table 24. Latin America TCR-Based Antibody Sales by Type (2018-2023) & (US$ Million) Table 25. Middle East and Africa TCR-Based Antibody Sales (K Units) by Type (2018-2023) Table 26. Middle East and Africa TCR-Based Antibody Sales by Type (2018-2023) & (US$ Million) Table 27. Global TCR-Based Antibody Sales by Company (2018-2023) & (K Units) Table 28. Global TCR-Based Antibody Sales Share by Company (2018-2023) Table 29. Global TCR-Based Antibody Revenue by Company (2018-2023) & (US$ Million) Table 30. Global TCR-Based Antibody Revenue Share by Company (2018-2023) Table 31. Global Market TCR-Based Antibody Price by Company (2018-2023) & (US$/Unit) Table 32. Global TCR-Based Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area Table 33. Global TCR-Based Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TCR-Based Antibody as of 2022) Table 35. Date of Key Manufacturers Enter into TCR-Based Antibody Market Table 36. Key Manufacturers TCR-Based Antibody Product Type Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global TCR-Based Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029 Table 39. Global TCR-Based Antibody Sales by Region (2018-2023) & (K Units) Table 40. Global TCR-Based Antibody Sales Market Share in Volume by Region (2018-2023) Table 41. Global TCR-Based Antibody Sales by Region (2018-2023) & (US$ Million) Table 42. Global TCR-Based Antibody Sales Market Share in Value by Region (2018-2023) Table 43. Global TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 44. Global TCR-Based Antibody Sales by Region (2024-2029) & (K Units) Table 45. Global TCR-Based Antibody Sales Market Share in Volume by Region (2024-2029) Table 46. Global TCR-Based Antibody Sales by Region (2024-2029) & (US$ Million) Table 47. Global TCR-Based Antibody Sales Market Share in Value by Region (2024-2029) Table 48. Global TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029) Table 49. Global TCR-Based Antibody Sales by Application: 2018 VS 2022 VS 2029 (US$ Million) Table 50. Global TCR-Based Antibody Sales by Application (2018-2023) & (K Units) Table 51. Global TCR-Based Antibody Sales Market Share in Volume by Application (2018-2023) Table 52. Global TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 53. Global TCR-Based Antibody Sales Market Share in Value by Application (2018-2023) Table 54. Global TCR-Based Antibody Price by Application (2018-2023) & (US$/Unit) Table 55. Global TCR-Based Antibody Sales by Application (2024-2029) & (K Units) Table 56. Global TCR-Based Antibody Sales Market Share in Volume by Application (2024-2029) Table 57. Global TCR-Based Antibody Sales by Application (2024-2029) & (US$ Million) Table 58. Global TCR-Based Antibody Sales Market Share in Value by Application (2024-2029) Table 59. Global TCR-Based Antibody Price by Application (2024-2029) & (US$/Unit) Table 60. North America TCR-Based Antibody Sales by Application (2018-2023) (K Units) Table 61. North America TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 62. Europe TCR-Based Antibody Sales by Application (2018-2023) (K Units) Table 63. Europe TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 64. Asia-Pacific TCR-Based Antibody Sales by Application (2018-2023) (K Units) Table 65. Asia-Pacific TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 66. Latin America TCR-Based Antibody Sales by Application (2018-2023) (K Units) Table 67. Latin America TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 68. Middle East and Africa TCR-Based Antibody Sales by Application (2018-2023) (K Units) Table 69. Middle East and Africa TCR-Based Antibody Sales by Application (2018-2023) & (US$ Million) Table 70. North America TCR-Based Antibody Sales by Country (2018-2023) & (K Units) Table 71. North America TCR-Based Antibody Sales Market Share in Volume by Country (2018-2023) Table 72. North America TCR-Based Antibody Sales by Country (2018-2023) & (US$ Million) Table 73. North America TCR-Based Antibody Sales Market Share in Value by Country (2018-2023) Table 74. North America TCR-Based Antibody Sales by Country (2024-2029) & (K Units) Table 75. North America TCR-Based Antibody Sales Market Share in Volume by Country (2024-2029) Table 76. North America TCR-Based Antibody Sales by Country (2024-2029) & (US$ Million) Table 77. North America TCR-Based Antibody Sales Market Share in Value by Country (2024-2029) Table 78. Europe TCR-Based Antibody Sales by Country (2018-2023) & (K Units) Table 79. Europe TCR-Based Antibody Sales Market Share in Volume by Country (2018-2023) Table 80. Europe TCR-Based Antibody Sales by Country (2018-2023) & (US$ Million) Table 81. Europe TCR-Based Antibody Sales Market Share in Value by Country (2018-2023) Table 82. Europe TCR-Based Antibody Sales by Country (2024-2029) & (K Units) Table 83. Europe TCR-Based Antibody Sales Market Share in Volume by Country (2024-2029) Table 84. Europe TCR-Based Antibody Sales by Country (2024-2029) & (US$ Million) Table 85. Europe TCR-Based Antibody Sales Market Share in Value by Country (2024-2029) Table 86. Asia-Pacific TCR-Based Antibody Sales by Region (2018-2023) & (K Units) Table 87. Asia-Pacific TCR-Based Antibody Sales Market Share in Volume by Region (2018-2023) Table 88. Asia-Pacific TCR-Based Antibody Sales by Region (2018-2023) & (US$ Million) Table 89. Asia-Pacific TCR-Based Antibody Sales Market Share in Value by Region (2018-2023) Table 90. Asia-Pacific TCR-Based Antibody Sales by Region (2024-2029) & (K Units) Table 91. Asia-Pacific TCR-Based Antibody Sales Market Share in Volume by Region (2024-2029) Table 92. Asia-Pacific TCR-Based Antibody Sales by Region (2024-2029) & (US$ Million) Table 93. Asia-Pacific TCR-Based Antibody Sales Market Share in Value by Region (2024-2029) Table 94. Latin America TCR-Based Antibody Sales by Country (2018-2023) & (K Units) Table 95. Latin America TCR-Based Antibody Sales Market Share in Volume by Country (2018-2023) Table 96. Latin America TCR-Based Antibody Sales by Country (2018-2023) & (US$ Million) Table 97. Latin America TCR-Based Antibody Sales Market Share in Value by Country (2018-2023) Table 98. Latin America TCR-Based Antibody Sales by Country (2024-2029) & (K Units) Table 99. Latin America TCR-Based Antibody Sales Market Share in Volume by Country (2024-2029) Table 100. Latin America TCR-Based Antibody Sales by Country (2024-2029) & (US$ Million) Table 101. Latin America TCR-Based Antibody Sales Market Share in Value by Country (2024-2029) Table 102. Middle East and Africa TCR-Based Antibody Sales by Country (2018-2023) & (K Units) Table 103. Middle East and Africa TCR-Based Antibody Sales Market Share in Volume by Country (2018-2023) Table 104. Middle East and Africa TCR-Based Antibody Sales by Country (2018-2023) & (US$ Million) Table 105. Middle East and Africa TCR-Based Antibody Sales Market Share in Value by Country (2018-2023) Table 106. Middle East and Africa TCR-Based Antibody Sales by Country (2024-2029) & (K Units) Table 107. Middle East and Africa TCR-Based Antibody Sales Market Share in Volume by Country (2024-2029) Table 108. Middle East and Africa TCR-Based Antibody Sales by Country (2024-2029) & (US$ Million) Table 109. Middle East and Africa TCR-Based Antibody Sales Market Share in Value by Country (2024-2029) Table 110. Adaptimmune Therapeutics Company Information Table 111. Adaptimmune Therapeutics Introduction and Business Overview Table 112. Adaptimmune Therapeutics TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Adaptimmune Therapeutics TCR-Based Antibody Product Table 114. Adaptimmune Therapeutics Recent Development Table 115. Celgene Company Information Table 116. Celgene Introduction and Business Overview Table 117. Celgene TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Celgene TCR-Based Antibody Product Table 119. Celgene Recent Development Table 120. Immunocore Company Information Table 121. Immunocore Introduction and Business Overview Table 122. Immunocore TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Immunocore TCR-Based Antibody Product Table 124. Immunocore Recent Development Table 125. Kuur Therapeutics Company Information Table 126. Kuur Therapeutics Introduction and Business Overview Table 127. Kuur Therapeutics TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. Kuur Therapeutics TCR-Based Antibody Product Table 129. Kuur Therapeutics Recent Development Table 130. Lion TCR Company Information Table 131. Lion TCR Introduction and Business Overview Table 132. Lion TCR TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. Lion TCR TCR-Based Antibody Product Table 134. Lion TCR Recent Development Table 135. Kite Pharma Company Information Table 136. Kite Pharma Introduction and Business Overview Table 137. Kite Pharma TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 138. Kite Pharma TCR-Based Antibody Product Table 139. Kite Pharma Recent Development Table 140. Takara Bio Company Information Table 141. Takara Bio Introduction and Business Overview Table 142. Takara Bio TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 143. Takara Bio TCR-Based Antibody Product Table 144. Takara Bio Recent Development Table 145. Ziopharm Oncology Company Information Table 146. Ziopharm Oncology Introduction and Business Overview Table 147. Ziopharm Oncology TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 148. Ziopharm Oncology TCR-Based Antibody Product Table 149. Ziopharm Oncology Recent Development Table 150. GlaxoSmithKline Company Information Table 151. GlaxoSmithKline Introduction and Business Overview Table 152. GlaxoSmithKline TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 153. GlaxoSmithKline TCR-Based Antibody Product Table 154. GlaxoSmithKline Recent Development Table 155. Merck Company Information Table 156. Merck Introduction and Business Overview Table 157. Merck TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 158. Merck TCR-Based Antibody Product Table 159. Merck Recent Development Table 160. Juno Theraprutics Company Information Table 161. Juno Theraprutics Introduction and Business Overview Table 162. Juno Theraprutics TCR-Based Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 163. Juno Theraprutics TCR-Based Antibody Product Table 164. Juno Theraprutics Recent Development Table 165. Key Raw Materials Lists Table 166. Raw Materials Key Suppliers Lists Table 167. TCR-Based Antibody Market Trends Table 168. TCR-Based Antibody Market Drivers Table 169. TCR-Based Antibody Market Challenges Table 170. TCR-Based Antibody Market Restraints Table 171. TCR-Based Antibody Distributors List Table 172. TCR-Based Antibody Downstream Customers Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. TCR-Based Antibody Product Picture Figure 2. Global TCR-Based Antibody Market Size, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global TCR-Based Antibody Market Size Status and Outlook (2018-2029) & (US$ Million) Figure 4. Global TCR-Based Antibody Sales Status and Outlook (2018-2029) & (K Units) Figure 5. Product Picture of NY-ESO-1 Figure 6. Global NY-ESO-1 Sales YoY Growth (2018-2029) & (K Units) Figure 7. Product Picture of p53 Figure 8. Global p53 Sales YoY Growth (2018-2029) & (K Units) Figure 9. Product Picture of WT-1 Figure 10. Global WT-1 Sales YoY Growth (2018-2029) & (K Units) Figure 11. Product Picture of EBv Figure 12. Global EBv Sales YoY Growth (2018-2029) & (K Units) Figure 13. Product Picture of Others Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 15. Global TCR-Based Antibody Sales by Type (2018-2029) & (US$ Million) Figure 16. Global TCR-Based Antibody Sales Market Share by Type in 2022 & 2029 Figure 17. North America TCR-Based Antibody Sales Market Share in Volume by Type in 2022 Figure 18. North America TCR-Based Antibody Sales Market Share in Value by Type in 2022 Figure 19. Europe TCR-Based Antibody Sales Market Share in Volume by Type in 2022 Figure 20. Europe TCR-Based Antibody Sales Market Share in Value by Type in 2022 Figure 21. Asia-Pacific TCR-Based Antibody Sales Market Share in Volume by Type in 2022 Figure 22. Asia-Pacific TCR-Based Antibody Sales Market Share in Value by Type in 2022 Figure 23. Latin America TCR-Based Antibody Sales Market Share in Volume by Type in 2022 Figure 24. Latin America TCR-Based Antibody Sales Market Share in Value by Type in 2022 Figure 25. Middle East and Africa TCR-Based Antibody Sales Market Share in Volume by Type in 2022 Figure 26. Middle East and Africa TCR-Based Antibody Sales Market Share in Value by Type in 2022 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by TCR-Based Antibody Sales in 2022 Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by TCR-Based Antibody Revenue in 2022 Figure 29. TCR-Based Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 30. Product Picture of Hospitals Figure 31. Global Hospitals Sales YoY Growth (2018-2029) & (K Units) Figure 32. Product Picture of Specialized Clinics Figure 33. Global Specialized Clinics Sales YoY Growth (2018-2029) & (K Units) Figure 34. Product Picture of Pharma and Biotech Research Laboratories. Figure 35. Global Pharma and Biotech Research Laboratories. Sales YoY Growth (2018-2029) & (K Units) Figure 36. Product Picture of Gene Therapy Centers Figure 37. Global Gene Therapy Centers Sales YoY Growth (2018-2029) & (K Units) Figure 38. Product Picture of Others Figure 39. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 40. Global TCR-Based Antibody Sales by Application (2018-2029) & (US$ Million) Figure 41. Global TCR-Based Antibody Sales Market Share by Application in 2022 & 2029 Figure 42. North America TCR-Based Antibody Sales Market Share in Volume by Application in 2022 Figure 43. North America TCR-Based Antibody Sales Market Share in Value by Application in 2022 Figure 44. Europe TCR-Based Antibody Sales Market Share in Volume by Application in 2022 Figure 45. Europe TCR-Based Antibody Sales Market Share in Value by Application in 2022 Figure 46. Asia-Pacific TCR-Based Antibody Sales Market Share in Volume by Application in 2022 Figure 47. Asia-Pacific TCR-Based Antibody Sales Market Share in Value by Application in 2022 Figure 48. Latin America TCR-Based Antibody Sales Market Share in Volume by Application in 2022 Figure 49. Latin America TCR-Based Antibody Sales Market Share in Value by Application in 2022 Figure 50. Middle East and Africa TCR-Based Antibody Sales Market Share in Value by Application in 2022 Figure 51. Key Raw Materials Price Figure 52. TCR-Based Antibody Manufacturing Cost Structure Figure 53. TCR-Based Antibody Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them. TCR-Based Antibody report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TCR-Based Antibody market is projected to reach US$ 1787.4 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2029. Demand from Hospitals and Specialized Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TCR-Based Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, TCR-Based Antibody key manufacturers include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. Adaptimmune Therapeutics, Celgene, Immunocore are top 3 players and held % sales share in total in 2022. TCR-Based Antibody can be divided into NY-ESO-1, p53, WT-1 and EBv, etc. NY-ESO-1 is the mainstream product in the market, accounting for % sales share globally in 2022. TCR-Based Antibody is widely used in various fields, such as Hospitals, Specialized Clinics, Pharma and Biotech Research Laboratories. and Gene Therapy Centers, etc. Hospitals provides greatest supports to the TCR-Based Antibody industry development. In 2022, global % sales of TCR-Based Antibody went into Hospitals filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global TCR-Based Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Adaptimmune Therapeutics Celgene Immunocore Kuur Therapeutics Lion TCR Kite Pharma Takara Bio Ziopharm Oncology GlaxoSmithKline Merck Juno Theraprutics Segment by Type NY-ESO-1 p53 WT-1 EBv Others Segment by Application Hospitals Specialized Clinics Pharma and Biotech Research Laboratories. Gene Therapy Centers Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the TCR-Based Antibody market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TCR-Based Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TCR-Based Antibody industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of TCR-Based Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TCR-Based Antibody introduction, etc. TCR-Based Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of TCR-Based Antibody market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now